Abrysvo

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Jul 14, 2026
Approval ID: be18292e-b1a2-4815-a0ed-003efaa6bea3
Products: 2 registered
Version: 15

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ABRYSVO safely and effectively. See full prescribing information for ABRYSVO. ABRYSVO (Respiratory Syncytial Virus Vaccine) for injection, for intramuscular useInitial U.S. Approval: 2023

Quick Stats

Total Products2

Labelers2

Label Sections41

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.